A. Cadena-Fernández

Incidence of Guillain-Barre syndrome following SARS-CoV-2 immunization in Mexico: A nationwide registry of seven COVID-19 vaccines

G. Reyes-Terán, J. Galnares-Olalde, M. García‐Grimshaw, 2022, medRxiv.

Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines

N. Antonio-Villa, H. Lopez-Gatell, G. Reyes-Terán, 2022, European journal of neurology.

Cyclophosphamide treatment in active multiple sclerosis

J. Flores-Rivera, Adriana Casallas-Vanegas, E. Gómez‐Figueroa, 2021, Neurological Sciences.

Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study

H. Lopez-Gatell, G. Reyes-Terán, A. Arauz, 2021, Vaccine.

Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes

S. Valdés-Ferrer, C. Cantú-Brito, E. Chiquete, 2022, Lupus.

Cognitive effects of chronic sleep deprivation in internal medicine residents

S. Valdés-Ferrer, C. Cantú-Brito, A. Gulias-Herrero, 2021 .

COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19

M. Mercado, Dalia Cuenca, A. Cadena-Fernández, 2021, PloS one.